Immunologic Significance of CD80/CD86 or Major Histocompatibility Complex-II Expression in Thymic Epithelial Tumors

Introduction: Unresectable or recurrent thymic epithelial tumors (TETs) have a poor prognosis, and treatment options are limited. This study aimed to investigate the immunologic significance of CD80/CD86 or major histocompatibility complex class II (MHC-II) expression in TETs, as potential predictiv...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Hideki Ikeda, MD, Joji Nagasaki, MD, PhD, Daiki Shimizu, MD, Yuki Katsuya, MD, PhD, Hidehito Horinouchi, MD, PhD, Yukio Hosomi, MD, PhD, Etsuko Tanji, MS, Takekazu Iwata, MD, PhD, Makiko Itami, MD, PhD, Masahito Kawazu, MD, PhD, Yuichiro Ohe, MD, PhD, Takuji Suzuki, MD, PhD, Yosuke Togashi, MD, PhD
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2023-10-01
Serija:	JTO Clinical and Research Reports
Teme:	Thymic epithelial tumor Cancer immunotherapy CD80/CD86 MHC Memory precursor effector T cell
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2666364323001169
Oznake:	Označite Brez oznak, prvi označite!